Status:

COMPLETED

Intestinal Microbiota and Their Antibiotic Resistance Genes of ICU Health Care Workers

Lead Sponsor:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions:

Intensive Care Unit

Eligibility:

All Genders

25-40 years

Brief Summary

In this study, metagenomic sequencing (10G) results of stool samples from health care workers in ICU and non-medical professionals were compared to observe whether there are significant differences in...

Detailed Description

The infection rate of multidrug-resistant bacteria in critically ill patients in intensive care unit (ICU) is high, resulting in high mortality, prolonged hospitalization, and becoming a source of pat...

Eligibility Criteria

Inclusion

  • Inclusion criteria for ICU health care workers: 25≤ age ≤40 years old, regardless of ethnicity or gender; Doctors and nurses who provide direct treatment and care for ICU patients, who have been working in ICU for ≥5 years, and who have been absent from frontline work continuously for \< 1 month; Agree to sign informed consent.
  • Inclusion criteria for non-medical professionals: 25≤ age ≤40 years old, regardless of ethnicity or gender; Age, sex, and body mass index matched with ICU medical staff; No hospitalization within the last year; Not an ICU health care worker or does not live with an ICU health care worker; Agree to sign informed consent.

Exclusion

  • Active gastrointestinal infection or chronic gastrointestinal disease;
  • Significant dietary changes or significant weight fluctuations (gain or loss \> 5 kg) within 3 months;
  • Antibiotics, proton pump inhibitors or prebiotics, probiotics , including yogurt, have been used in the past 4 weeks;
  • Drinking within the past week;
  • Those who have recently been treated with high-risk immunosuppressive or cytotoxic drugs, such as medium-high dose steroid hormones (20 mg/day or higher) for more than 4 weeks;
  • History of major gastrointestinal surgery;
  • Chronic diseases that may affect the gut microbiota;
  • Congenital or acquired immunodeficiency disease;
  • Do not agree to provide information about their diet, exercise and other lifestyle factors that may affect the composition of their microbiome;
  • Pregnant or lactating women;
  • Participate in other clinical studies at the time of enrollment or within 3 months before enrollment;
  • Do not agree to sign a written informed consent.

Key Trial Info

Start Date :

August 4 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 16 2024

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT06524765

Start Date

August 4 2024

End Date

October 16 2024

Last Update

December 10 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China, 430022